Zydus Lifesciences News

Zydus Launches India's First Foldable Inhaler Device

Zydus Lifesciences introduces Aerolife Mini™, India's first portable and foldable spacer device for asthma and COPD patients under exclusive licensing arrangement with AeroDel Technology.

Zydus Partners Torrent for Semaglutide Co-Marketing

Zydus Lifesciences signs licensing agreement with Torrent Pharma for co-marketing semaglutide injection in India, expanding strategic partnerships beyond existing Lupin collaboration.

Zydus Lifesciences Partners Lupin for Semaglutide

Zydus Lifesciences enters co-marketing agreement with Lupin to promote semaglutide injection in India under multiple brand names across both companies' portfolios.

Zydus Unit Licenses Progeria Treatment Molecule

Sentynl Therapeutics, Zydus subsidiary, enters licensing agreement with PRG S&T for investigational drug Progerinin to treat rare genetic disorder Hutchinson-Gilford Progeria Syndrome.

Zydus' Desidustat Gets NMPA Approval in China

Zydus Lifesciences' innovative drug Desidustat receives approval from China's NMPA for treating renal anaemia, licensed to China Medical System Holdings for commercialization across Greater China.